文献速递流行病学与生物统计真实世界研究与卫生经济

带自适应偏倚校正的贝叶斯安全性监测

Bayesian safety surveillance with adaptive bias correction.
PubMed 文献 · Stat Med · 2023-11-27

本文提出一种贝叶斯安全性监测方法,通过联合分析大量阴性对照结局构建经验偏倚分布并纳入贝叶斯分层模型以校正残余混杂,同时利用后验概率进行序贯安全性信号检测。

要点

  • 贝叶斯监测联合阴性对照结局构建偏倚分布,经分层模型校正残余混杂。
  • 基于后验概率序贯检测安全性信号,较MaxSPRT大幅降低I类错误率。
  • 在六个美国数据库中保持高统计功效与快速信号检测,估计更准确。

核心结论

  • 所提出的贝叶斯监测方法较MaxSPRT大幅降低I类错误率、保持高统计功效与快速信号检测,并提供更准确的估计。

研究设计与样本

  • 方法学研究,提出贝叶斯序贯安全性监测程序,联合分析大量阴性对照结局以构建经验偏倚分布并纳入贝叶斯分层模型估计疫苗暴露对目标不良事件的影响。

主要发现

  • 所提方法较MaxSPRT大幅降低I类错误率。
  • 所提方法保持高统计功效与快速信号检测。
  • 所提方法较MaxSPRT提供更准确的估计。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Postmarket safety surveillance is an integral part of mass vaccination programs. Typically relying on sequential analysis of real-world health data as they accrue, safety surveillance is challenged by sequential multiple testing and by biases induced by residual confounding in observational data. The current standard approach based on the maximized sequential probability ratio test (MaxSPRT) fails to satisfactorily address these practical challenges and it remains a rigid framework that requires prespecification of the surveillance schedule. We develop an alternative Bayesian surveillance procedure that addresses both aforementioned challenges using a more flexible framework. To mitigate bias, we jointly analyze a large set of negative control outcomes that are adverse events with no known association with the vaccines in order to inform an empirical bias distribution, which we then incorporate into estimating the effect of vaccine exposure on the adverse event of interest through a Bayesian hierarchical model. To address multiple testing and improve on flexibility, at each analysis timepoint, we update a posterior probability in favor of the alternative hypothesis that vaccination induces higher risks of adverse events, and then use it for sequential detection of safety signals. Through an empirical evaluation using six US observational healthcare databases covering more than 360 million patients, we benchmark the proposed procedure against MaxSPRT on testing errors and estimation accuracy, under two epidemiological designs, the historical comparator and the self-controlled case series. We demonstrate that our procedure substantially reduces Type 1 error rates, maintains high statistical power and fast signal detection, and provides considerably more accurate estimation than MaxSPRT. Given the extensiveness of the empirical study which yields more than 7 million sets of results, we present all results in a public R ShinyApp. As an effort to promote open science, we provide full implementation of our method in the open-source R package EvidenceSynthesis.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Bu F, Schuemie MJ, Nishimura A, et al. Bayesian safety surveillance with adaptive bias correction. Stat Med. 2023. PMID: 38010062. doi:10.1002/sim.9968

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。